Correlation Between Handa Pharmaceuticals and Synmosa Biopharma

Can any of the company-specific risk be diversified away by investing in both Handa Pharmaceuticals and Synmosa Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Handa Pharmaceuticals and Synmosa Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Handa Pharmaceuticals and Synmosa Biopharma, you can compare the effects of market volatilities on Handa Pharmaceuticals and Synmosa Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Handa Pharmaceuticals with a short position of Synmosa Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Handa Pharmaceuticals and Synmosa Biopharma.

Diversification Opportunities for Handa Pharmaceuticals and Synmosa Biopharma

-0.35

Correlation Coefficient

Handa Pharmaceuticals  Synmosa Biopharma

Very good diversification

The 3 months correlation between Handa and Synmosa is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Handa Pharmaceuticals and Synmosa Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Synmosa Biopharma and Handa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Handa Pharmaceuticals are associated (or correlated) with Synmosa Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Synmosa Biopharma has no effect on the direction of Handa Pharmaceuticals i.e., Handa Pharmaceuticals and Synmosa Biopharma go up and down completely randomly.

Pair Corralation between Handa Pharmaceuticals and Synmosa Biopharma

Assuming the 90 days trading horizon Handa Pharmaceuticals is expected to generate 3.31 times more return on investment than Synmosa Biopharma. However, Handa Pharmaceuticals is 3.31 times more volatile than Synmosa Biopharma. It trades about 0.1 of its potential returns per unit of risk. Synmosa Biopharma is currently generating about -0.01 per unit of risk. If you would invest  7,480  in Handa Pharmaceuticals on December 31, 2024 and sell it today you would earn a total of  1,080  from holding Handa Pharmaceuticals or generate 14.44% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Handa Pharmaceuticals  vs.  Synmosa Biopharma

Handa Pharmaceuticals

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Handa Pharmaceuticals are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Handa Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Synmosa Biopharma

Risk-Adjusted Performance

Very Weak

Over the last 90 days Synmosa Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Synmosa Biopharma is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Handa Pharmaceuticals and Synmosa Biopharma

The main advantage of trading using opposite Handa Pharmaceuticals and Synmosa Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Handa Pharmaceuticals position performs unexpectedly, Synmosa Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Synmosa Biopharma will offset losses from the drop in Synmosa Biopharma's long position.

The idea behind Handa Pharmaceuticals and Synmosa Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.